Sairopa Achieves Research Milestones in Exelixis, $35M in Payments
17 Dec 2024 //
PR NEWSWIRE
Exelixis and Sairopa Announce US FDA Clears Investigational NDA for ADU-1805
13 Feb 2023 //
BUSINESSWIRE
Exelixis & Sairopa Establish Exclusive Clinical Collaboration Agreement ADU-1805
01 Nov 2022 //
BUSINESSWIRE